ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Washington » Internal Medicine

Top Internal Medicine Prescribers in Washington

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
RICHARD KIRKPATRICK M.D.

Internal Medicine

19,748

$1.51M

864
653 are 65+

17%
patients receiving schedule two controlled substances

Avg: 7%

14%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

33%
prescriptions for brand name drugs

Avg: 23%

$77
Average prescription price

Avg: $56

JHOANNA SANTOS MD

Internal Medicine

12,480

$682K

552
487 are 65+

10%
patients receiving schedule two controlled substances

Avg: 7%

14%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$55
Average prescription price

Avg: $56

YOUNG LEE MD

Internal Medicine

22,042

$1.91M

950
878 are 65+

2%
patients receiving schedule two controlled substances

Avg: 7%

5%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

43%
prescriptions for brand name drugs

Avg: 23%

$87
Average prescription price

Avg: $56

SALONA SHRESTHA MD

Internal Medicine

2,810

$138K

364
289 are 65+

15%
patients receiving schedule two controlled substances

Avg: 7%

14%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 23%

$49
Average prescription price

Avg: $56

AARON ANDERSON D.O.

Internal Medicine

7,544

$432K

421
310 are 65+

8%
patients receiving schedule two controlled substances

Avg: 7%

25%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 23%

$57
Average prescription price

Avg: $56

MAX LEE MD

Internal Medicine

2,975

$191K

156
145 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

8%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 23%

$64
Average prescription price

Avg: $56

CHRISTEN EIDAL MD

Internal Medicine

934

$52.9K

173
121 are 65+

21%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 23%

$57
Average prescription price

Avg: $56

DANIEL DOORNINK MD

Internal Medicine

5,428

$287K

573
518 are 65+

3%
patients receiving schedule two controlled substances

Avg: 7%

10%
patients receiving schedule three controlled substances

Avg: 10%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 23%

$53
Average prescription price

Avg: $56

J SWIFT MD

Internal Medicine

2,276

$172K

100
87 are 65+

11%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 23%

$76
Average prescription price

Avg: $56

MARTHA HYDE MD

Internal Medicine

5,549

$216K

286
248 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

9%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 23%

$39
Average prescription price

Avg: $56

DOUGLAS PAAUW

Internal Medicine

2,473

$293K

88
71 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 23%

$119
Average prescription price

Avg: $56

J GOSS MD

Internal Medicine

2,148

$56.9K

45
32 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 23%

$26
Average prescription price

Avg: $56

LESLIE ENZIAN

Internal Medicine

2,227

$80.9K

74
23 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 23%

$36
Average prescription price

Avg: $56

MADHURINA ROY MD

Internal Medicine

1,404

$71.8K

62
49 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

35%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 23%

$51
Average prescription price

Avg: $56

PATSY LAZAROUS MD

Internal Medicine

4,383

$217K

238
206 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

11%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 23%

$49
Average prescription price

Avg: $56

PATRICIA MARTIN MD

Internal Medicine

1,613

$72.8K

129
112 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 23%

$45
Average prescription price

Avg: $56

ELIZABETH POTTER MD

Internal Medicine

582

$24.9K

42
23 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 23%

$43
Average prescription price

Avg: $56

ELIZABETH HO MD

Internal Medicine

3,248

$173K

191
167 are 65+

6%
patients receiving schedule two controlled substances

Avg: 7%

10%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 23%

$53
Average prescription price

Avg: $56

NANCY CONNOLLY M.D., M.P.H.

Internal Medicine

1,633

$129K

166
119 are 65+

11%
patients receiving schedule two controlled substances

Avg: 7%

10%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 23%

$79
Average prescription price

Avg: $56

ANTONIUS MULIA M.D.

Internal Medicine

2,436

$111K

208
186 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

7%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 23%

$45
Average prescription price

Avg: $56

CORIE SANDALL MD

Internal Medicine

10,950

$835K

507
373 are 65+

11%
patients receiving schedule two controlled substances

Avg: 7%

13%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 23%

$76
Average prescription price

Avg: $56

ALAN FINE M.D.

Internal Medicine

3,899

$147K

344
308 are 65+

8%
patients receiving schedule two controlled substances

Avg: 7%

9%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 23%

$38
Average prescription price

Avg: $56

CHRISTINE KAISER M.D.

Internal Medicine

467

$243K

122
106 are 65+

10%
patients receiving schedule two controlled substances

Avg: 7%

15%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

11%
prescriptions for brand name drugs

Avg: 23%

$521
Average prescription price

Avg: $56

ALICE KIM M.D.

Internal Medicine

3,214

$172K

270
210 are 65+

6%
patients receiving schedule two controlled substances

Avg: 7%

6%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 23%

$53
Average prescription price

Avg: $56

KANG ZHANG M.D.

Internal Medicine

554

$15.5K

39
23 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

12%
prescriptions for brand name drugs

Avg: 23%

$28
Average prescription price

Avg: $56

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank